Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 6,493,900 | 5,506,700 | 4,842,100 | 3,625,745 | 2,689,893 |
| Cost of Goods | 340,400 | 299,100 | 425,900 | 306,521 | 216,289 |
| Gross Profit | 6,153,500 | 5,207,600 | 4,416,200 | 3,319,224 | 2,473,604 |
| Operating Expenses | 4,345,000 | 3,461,300 | 2,974,400 | 2,330,110 | 1,632,367 |
| Operating Income | 1,808,900 | 1,746,400 | 1,442,700 | 989,635 | 841,526 |
| Interest Expense | 91,600 | 63,200 | 42,700 | 12,634 | 1,966 |
| Other Income | -51,900 | -1,700 | 19,500 | 35,609 | 136,143 |
| Pre-tax Income | 1,665,400 | 1,681,500 | 1,419,500 | 1,012,610 | 975,703 |
| Income Tax | 215,500 | 225,300 | 102,100 | 132,418 | 198,956 |
| Net Income Continuous | 1,449,900 | 1,456,200 | 1,317,400 | 880,192 | 776,747 |
| Minority Interests | N/A | N/A | -700 | -320 | 0 |
| Net Income | $1,449,900 | $1,456,200 | $1,318,100 | $880,512 | $776,747 |
| EPS Basic Total Ops | 1.75 | 1.69 | 1.45 | 0.95 | 0.85 |
| EPS Basic Continuous Ops | 1.75 | 1.69 | 1.45 | 0.95 | 0.85 |
| EPS Diluted Total Ops | 1.68 | 1.65 | 1.43 | 0.94 | 0.83 |
| EPS Diluted Continuous Ops | 1.68 | 1.65 | 1.42 | 0.94 | 0.83 |
| EPS Diluted Before Non-Recurring Items | 2.68 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $2,183,000 | $2,029,900 | $1,805,600 | $1,248,724 | $967,594 |